HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

BI 6727

a polo-like kinase inhibitor with broad antitumor activity; structure in first source
Networked: 16 relevant articles (0 outcomes, 5 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Louwen, Frank: 2 articles (10/2015 - 02/2012)
2. Yuan, Juping: 2 articles (10/2015 - 02/2012)
3. Sanhaji, Mourad: 2 articles (01/2015 - 02/2012)
4. Becker, Sven: 2 articles (01/2015 - 01/2015)
5. Strebhardt, Klaus: 2 articles (01/2015 - 01/2015)
6. Carducci, Michael A: 2 articles (04/2014 - 10/2013)
7. Adjan, Mouhib: 1 article (10/2015)
8. Fornoff, Friderike: 1 article (10/2015)
9. Ritter, Andreas: 1 article (10/2015)
10. Solbach, Christine: 1 article (10/2015)

Related Diseases

1. Neoplasms (Cancer)
2. Carcinoma (Carcinomatosis)
3. Breast Neoplasms (Breast Cancer)
4. Tics (Tic)
5. Melanoma (Melanoma, Malignant)

Related Drugs and Biologics

1. BI 2536
2. Small Interfering RNA (siRNA)
3. Phosphotransferases (Kinase)
4. polo-like kinase 1
5. Proteome
6. 5- (5,6- dimethoxy- 1H- benzimidazol- 1- yl)- 3- ((2- (trifluoromethyl)benzyl)oxy)thiophene- 2- carboxamide
7. Adenosine Triphosphate (ATP)
8. Histone Deacetylase Inhibitors
9. Proteasome Endopeptidase Complex (Proteasome)
10. taxane

Related Therapies and Procedures

1. Aftercare (After-Treatment)